InflaRx N.V. (IFRX) reporting calendar
InflaRx N.V. files periodic reports with the SEC as IFRX on Nasdaq. Atlas tracks 9 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 20-F
- Period ended
- 31 Dec 2025
- Filed
- 20 Mar 2026
- Reports on record
- 9
Open IFRX market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 20-F | 31 Dec 2025 | 20 Mar 2026 | 79 days | 0001213900-26-032065 |
| 20-F | 31 Dec 2024 | 20 Mar 2025 | 79 days | 0001213900-25-025292 |
| 20-F | 31 Dec 2023 | 21 Mar 2024 | 81 days | 0001213900-24-024500 |
| 20-F | 31 Dec 2022 | 22 Mar 2023 | 81 days | 0001213900-23-021874 |
| 20-F | 31 Dec 2021 | 24 Mar 2022 | 83 days | 0001654954-22-003707 |
| 20-F | 31 Dec 2020 | 25 Mar 2021 | 84 days | 0001140361-21-009911 |
| 20-F | 31 Dec 2019 | 29 Apr 2020 | 120 days | 0001140361-20-010155 |
| 20-F | 31 Dec 2018 | 28 Mar 2019 | 87 days | 0001140361-19-005788 |
| 20-F | 31 Dec 2017 | 29 Mar 2018 | 88 days | 0000950103-18-003977 |
Source: SEC EDGAR company submissions for CIK 0001708688. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.